Anti-SEPT9 antibody produced in mouse
SIGMA/SAB1407054 - purified immunoglobulin, buffered aqueous solution
Synonym: AF17q25; FLJ75490; KIAA0991; MSF; MSF1; NAPB; PNUTL4; SINT1; SeptD1
Product Type: Chemical
Western Blotting SEPT9 polyclonal antibody. Western Blot analysis of SEPT9 expression in HepG2.
Western Blotting Western Blot analysis of SEPT9 expression in transfected 293T cell line by SEPT9 polyclonal antibody. Lanes Lane 1: SEPT9 transfected lysate (62.48 kDa). Lane 2: Non-transfected lysate.
| antibody form | purified immunoglobulin |
| antibody product type | primary antibodies |
| biological source | mouse |
| clone | polyclonal |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| mol wt | antigen ~63.6 kDa |
| NCBI accession no. | NM_006640   |
| Quality Level | 100 |
| shipped in | dry ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | western blot: 1 μg/mL |
| General description: | This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described |
| Immunogen: | SEPT9 (AAH21192.1, 1 a.a. ~ 568 a.a) full-length human protein. Sequence MERDRISALKRSFEVEEVETPNSTP |
| Physical form: | Solution in phosphate buffered saline, pH 7.4 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |